Finally, when the combination treatment with VPA/JQ-1 was used against pancreatic cancer cells transfected with acetylation-deficient PD-L1K263R, it completely prevented the upregulation of PD-L1 induced by VPA on the cell surface (Fig. 4E). The gene discussed is CD274; the disease is pancreatic neoplasm.